Feng Qin Zhang
Directeur Financier/CFO chez Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Profil
Feng Qin Zhang is currently the Chief Financial Officer & Deputy General Manager at Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Zhang graduated from Renmin University of China with a graduate degree and from Shanxi University of Finance & Economics with an undergraduate degree.
Postes actifs de Feng Qin Zhang
| Sociétés | Poste | Début |
|---|---|---|
Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
 Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China. | Directeur Financier/CFO | - |
Formation de Feng Qin Zhang
| Shanxi University of Finance & Economics | Undergraduate Degree |
| Renmin University of China | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
 | Health Technology |